Free Trial
OTCMKTS:USRM

Bioheart (USRM) Stock Price, News & Analysis

Bioheart logo

About Bioheart Stock (OTCMKTS:USRM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
188,019 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive USRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioheart and its competitors with MarketBeat's FREE daily newsletter.

USRM Stock News Headlines

The Allure of Stem Cell Therapy
Miss This Window And You Miss Everything
There’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the phase when momentum builds, news turns bullish, and markets ignite. Inside The Crypto Code Workshop, you’ll get the roadmap to ride this wave — and $10 in free Bitcoin just for showing up.
See More Headlines

USRM Stock Analysis - Frequently Asked Questions

Bioheart Inc. (OTCMKTS:USRM) released its quarterly earnings results on Wednesday, August, 7th. The company reported $0.00 earnings per share for the quarter. The business earned $1.30 million during the quarter.

Shares of USRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioheart investors own include Actinium Pharmaceuticals (ATNM), Cleveland BioLabs (CBLI), Cannabis Wheaton Income (CBWTF), Meta Platforms (META), Nextech3D.AI (NEXCF) and Orion Energy Systems (OESX).

Company Calendar

Last Earnings
8/07/2019
Today
7/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Business Services
Current Symbol
OTCMKTS:USRM
Previous Symbol
NASDAQ:BHRT
CIK
1388319
Employees
11
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$80 thousand
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
-1.35

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:USRM) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners